Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer
- 1 February 1996
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 37 (1), 57-64
- https://doi.org/10.1007/bf01806632
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosisBreast Cancer Research and Treatment, 1994
- Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrencesEuropean Journal Of Cancer, 1993
- The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.The Journal of cell biology, 1993
- Age as prognostic factor in premenopausal breast carcinomaThe Lancet, 1993
- Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67Breast Cancer Research and Treatment, 1991
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- The long‐term prognostic significance of the thymidine labelling index in breast cancerInternational Journal of Cancer, 1984
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958